{"id":"W3012183740","doi":"10.1200/jco.2013.31.15_suppl.8545","title":"Results after long-term follow-up from the CAN2007 phase I/II study of weekly or twice-weekly bortezomib in patients (pts) with relapsed systemic light-chain (AL) amyloidosis.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bortezomib; Internal medicine; Phases of clinical research; Surgery; AL amyloidosis; Gastroenterology; Multiple myeloma; Toxicity; Immunoglobulin light chain","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004626671,0.000629331,0.001337514,0.000491141,0.0007967462,0.0009431275,0.0004318474,0.0009995393,0.002394935],"category_scores_gemma":[0.003412523,0.0002145096,0.001144461,0.0005527863,0.0004950945,0.0006325072,0.0007212149,0.001261995,0.0005128369],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000777635,"about_ca_system_score_gemma":0.0004887189,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001656485,"about_ca_topic_score_gemma":0.002120669,"domain_scores_codex":[0.9988089,0.0004745121,0.0001286223,0.0001786023,0.0001857597,0.0002236665],"domain_scores_gemma":[0.9952414,0.001196057,0.001000414,0.0003359134,0.0006832457,0.001542951],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.455634,0.01072336,0.4151433,0.00075789,0.005497672,0.001619804,0.0006675391,0.002580294,0.01385271,0.0001414192,0.007589597,0.08579246],"study_design_scores_gemma":[0.02326103,0.0907777,0.8701829,0.00007381758,0.004076853,0.001023557,0.0001796725,0.001017745,0.002852985,0.0001427537,0.006351626,0.00005935631],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9888601,0.004497814,0.0004122024,0.0002121967,0.00007394234,0.000311864,0.002673191,0.00003646948,0.002922236],"genre_scores_gemma":[0.9896615,0.0003673914,0.0001768015,0.0003248337,0.00006687563,0.0002420921,0.007700011,0.00001377918,0.001446701],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004626671,"threshold_uncertainty_score":0.02446848,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03643590247432078,"score_gpt":0.3702259658615275,"score_spread":0.3337900633872067,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}